2988 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 60 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
A1BGAlpha-1-B glycoproteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 3.97e-4
Tissue enrichedTissue enriched
A1CFAPOBEC1 complementation factorPredicted intracellular proteins
NucleoplasmTissue enrichedTissue enhanced
A4GNTAlpha-1,4-N-acetylglucosaminyltransferasePredicted secreted proteins
Group enrichedTissue enriched
AADACArylacetamide deacetylaseEnzymes
Predicted intracellular proteins
Ovarian cancer: 5.58e-6
Stomach cancer: 2.19e-4
Pancreatic cancer: 5.02e-4
Tissue enrichedGroup enriched
AARDAlanine and arginine rich domain containing proteinPredicted intracellular proteins
Lipid dropletsTissue enrichedTissue enriched
ABCA10ATP binding cassette subfamily A member 10Predicted intracellular proteins
Predicted membrane proteins
Transporters
MixedMixed
ABCA12ATP binding cassette subfamily A member 12Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoli
Vesicles
Plasma membrane
Cytosol
MixedGroup enriched
ABCA13ATP binding cassette subfamily A member 13Predicted membrane proteins
Vesicles
Centrosome
Cytosol
MixedTissue enriched
ABCA4ATP binding cassette subfamily A member 4Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Lung cancer: 2.45e-4
Urothelial cancer: 2.72e-4
Tissue enhancedTissue enhanced
ABCA6ATP binding cassette subfamily A member 6Predicted intracellular proteins
Predicted membrane proteins
Transporters
NucleoplasmLiver cancer: 3.29e-4
Tissue enrichedTissue enhanced
ABCA9ATP binding cassette subfamily A member 9Predicted membrane proteins
Transporters
Endoplasmic reticulumMixedMixed
ABCB11ATP binding cassette subfamily B member 11Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Tissue enrichedTissue enriched
ABCB5ATP binding cassette subfamily B member 5Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enrichedTissue enriched
ABCC11ATP binding cassette subfamily C member 11Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ABCC12ATP binding cassette subfamily C member 12Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhancedTissue enhanced
ABCC2ATP binding cassette subfamily C member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 1.93e-5
Tissue enhancedGroup enriched
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedTissue enhanced
ABCG5ATP binding cassette subfamily G member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleusLiver cancer: 2.60e-5
Tissue enrichedGroup enriched
ABCG8ATP binding cassette subfamily G member 8Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enrichedGroup enriched
ABHD1Abhydrolase domain containing 1Predicted membrane proteins
Predicted secreted proteins
MixedTissue enriched
ABHD12BAbhydrolase domain containing 12BPredicted intracellular proteins
NucleusTissue enrichedTissue enriched
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
MixedTissue enhanced
AC006116.20Predicted secreted proteins
MixedTissue enriched
AC009014.3Predicted membrane proteins
Liver cancer: 1.63e-4
Pancreatic cancer: 6.13e-4
Tissue enhancedTissue enhanced
AC011513.3Predicted secreted proteins
Tissue enhancedGroup enriched
AC092835.2Predicted intracellular proteins
MixedMixed
ACAD11Acyl-CoA dehydrogenase family member 11Predicted intracellular proteins
Tissue enhancedExpressed in all
ACCSL1-aminocyclopropane-1-carboxylate synthase homolog (inactive) likePredicted intracellular proteins
Tissue enrichedNot detected
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Renal cancer: 2.12e-5
Liver cancer: 4.21e-4
Tissue enhancedGroup enriched
ACER1Alkaline ceramidase 1Enzymes
Predicted membrane proteins
Group enrichedTissue enriched
ACKR2Atypical chemokine receptor 2G-protein coupled receptors
Predicted membrane proteins
Nucleoplasm
Vesicles
Cytosol
MixedTissue enhanced
ACKR4Atypical chemokine receptor 4G-protein coupled receptors
Predicted membrane proteins
Vesicles
Mitochondria
MixedMixed
ACMSDAminocarboxymuconate semialdehyde decarboxylaseEnzymes
Predicted intracellular proteins
Renal cancer: 2.39e-4
Group enrichedGroup enriched
ACOT12Acyl-CoA thioesterase 12Enzymes
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Liver cancer: 5.30e-4
Tissue enrichedTissue enriched
ACOXLAcyl-CoA oxidase-likePredicted intracellular proteins
Nucleoli
Cytosol
Urothelial cancer: 6.48e-4
Group enrichedGroup enriched
ACP7Acid phosphatase 7, tartrate resistant (putative)Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Group enrichedGroup enriched
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedTissue enriched
ACPTAcid phosphatase, testicularDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
MixedTissue enhanced
ACRV1Acrosomal vesicle protein 1Predicted secreted proteins
MixedTissue enriched
ACSM1Acyl-CoA synthetase medium-chain family member 1Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ACSM2AAcyl-CoA synthetase medium-chain family member 2AEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 1.41e-5
Group enrichedGroup enriched
ACSM2BAcyl-CoA synthetase medium-chain family member 2BEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 3.31e-4
Group enrichedGroup enriched
ACSM3Acyl-CoA synthetase medium-chain family member 3Enzymes
Predicted intracellular proteins
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
MixedTissue enhanced
ACSM6Acyl-CoA synthetase medium-chain family member 6Enzymes
Predicted membrane proteins
Urothelial cancer: 7.71e-4
Tissue enrichedTissue enhanced
ACTL10Actin like 10Predicted secreted proteins
MixedTissue enriched
ACTL8Actin like 8Predicted intracellular proteins
CytosolEndometrial cancer: 1.62e-6
Head and neck cancer: 7.02e-4
MixedTissue enriched
ACTN3Actinin alpha 3 (gene/pseudogene)Plasma proteins
Predicted intracellular proteins
Tissue enhancedTissue enriched
ACTR3CARP3 actin-related protein 3 homolog CPredicted intracellular proteins
MixedTissue enriched
ACTRT3Actin related protein T3Predicted intracellular proteins
NucleoplasmEndometrial cancer: 4.11e-4
MixedTissue enriched
ACVR1CActivin A receptor type 1CEnzymes
Predicted membrane proteins
Predicted secreted proteins
MixedTissue enriched
Page of 60 | next »